🔎 Trials Near Me

Hjem › Reumatoid arthritis › Massachusetts

Reumatoid arthritis kliniske forsøg i Massachusetts

8 studier for Reumatoid arthritis søger deltagere på steder i Massachusetts.

Byer i Massachusetts

Officiel studietekst (engelsk)

RA-PRO PRAGMATIC TRIAL

  • Tufts University, Boston
  • University of Massachusetts Chan Medical School, Worcester
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT04692493

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  • Massachusetts General Hospital, Boston
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 21. aug. 2026 · NCT06570798

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Brigham And Womens Hospital, Boston
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 14. jul. 2026 · NCT07115745

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

  • Massachusetts General Hospital: Rheumatology, Boston
  • Brigham and Womens Hospital, Boston
  • Brigham and Women's Faulkner Hospital, Boston
RekruttererObservationsstudie
Alder 35 til 79 · Alle køn · Opdateret 14. jul. 2026 · NCT07315997

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

  • Tufts University, Boston
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 30. jun. 2026 · NCT06201416

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

  • Research Site, New Bedford
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. jun. 2026 · NCT07276581

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

  • Tufts University, Boston
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
RekruttererObservationsstudie
Alder 18 til 71 · Alle køn · Opdateret 16. apr. 2026 · NCT07123038

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.